ADC Therapeutics

ADC Therapeutics

ADC Therapeutics

ADC Therapeutics develops antibody drug conjugates and non-antibody drugconjugate products.
Type
B2b
Founded
2011
Raised
$425M
Follow us
Alexa global traffic share
Latest funding Show all
$200,000,000
Private equity - 2017
Redmile Group AstraZeneca Auven Therapeutics
$105,000,000
Private equity - 2016
AstraZeneca Auven Therapeutics
Team Size
1–10
Employees
FinSMEs

ADC Therapeutics Completes $267M IPO

Xconomy

ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon

Xconomy

ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans

$105,000,000 Private equity
startupticker

ADC Therapeutics Announces Closing of $105 Million Private Financing Startupticker.ch | The Swiss Startup News channel

Health Funding